Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07430930 · ClinicalTrials.gov registry record · NA
Pragmatic Trial of Messaging to Providers About Treatment of Chronic Kidney Disease
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT07430930: Clinical Trial NA study, sponsored by Yale University.
NCT07430930 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07430930, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
This study is a cluster-randomized clinical trial to evaluate whether a tailored, user-centered, clinical decision support (CDS) tool can positively influence prescriber behavior and increase prescription of guideline-directed medical therapy (GDMT) among patients with Chronic Kidney Disease (CKD) across a single healthcare center.
Primary Outcome
Proportion of patient subjects with one or more new eligible GDMT prescriptions within 90 days of randomization.
Interventions
- OTHER Best practice alert and order set for CKD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-06 |
| Phase | NA |
What is known before NCT07430930 opens enrollment
NCT07430930 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 1 intervention - of which Best practice alert and order set for CKD is the first listed.
NCT07430930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07430930 about?
NCT07430930 is a clinical study titled "Pragmatic Trial of Messaging to Providers About Treatment of Chronic Kidney Disease". This study is a cluster-randomized clinical trial to evaluate whether a tailored, user-centered, clinical decision support (CDS) tool can positively influence prescriber behavior and increase prescription of guideline-directed medical therapy (GDMT) among patients with Chronic Kidney Disease (CKD) a...
What is the current status of trial NCT07430930?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2026-06. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07430930?
The interventions under investigation include: Best practice alert and order set for CKD (OTHER).
Who is sponsoring clinical trial NCT07430930?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07430930's enrollment target sits among peer trials
1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia